128 related articles for article (PubMed ID: 29654865)
1. Chemistry, biochemistry, metabolic fate and mechanism of action of 6-oxo-cholestan-3β,5α-diol (OCDO), a tumor promoter and cholesterol metabolite.
Poirot M; Soules R; Mallinger A; Dalenc F; Silvente-Poirot S
Biochimie; 2018 Oct; 153():139-149. PubMed ID: 29654865
[TBL] [Abstract][Full Text] [Related]
2. Identification of a tumor-promoter cholesterol metabolite in human breast cancers acting through the glucocorticoid receptor.
Voisin M; de Medina P; Mallinger A; Dalenc F; Huc-Claustre E; Leignadier J; Serhan N; Soules R; Ségala G; Mougel A; Noguer E; Mhamdi L; Bacquié E; Iuliano L; Zerbinati C; Lacroix-Triki M; Chaltiel L; Filleron T; Cavaillès V; Al Saati T; Rochaix P; Duprez-Paumier R; Franchet C; Ligat L; Lopez F; Record M; Poirot M; Silvente-Poirot S
Proc Natl Acad Sci U S A; 2017 Oct; 114(44):E9346-E9355. PubMed ID: 29078321
[TBL] [Abstract][Full Text] [Related]
3. 27-Hydroxylation of oncosterone by CYP27A1 switches its activity from pro-tumor to anti-tumor.
Ayadi S; Friedrichs S; Soulès R; Pucheu L; Lütjohann D; Silvente-Poirot S; Poirot M; de Medina P
J Lipid Res; 2023 Dec; 64(12):100479. PubMed ID: 37981011
[TBL] [Abstract][Full Text] [Related]
4. One step synthesis of 6-oxo-cholestan-3β,5α-diol.
Voisin M; Silvente-Poirot S; Poirot M
Biochem Biophys Res Commun; 2014 Apr; 446(3):782-5. PubMed ID: 24508258
[TBL] [Abstract][Full Text] [Related]
5. Improvement of 5,6α-epoxycholesterol, 5,6β-epoxycholesterol, cholestane-3β,5α,6β-triol and 6-oxo-cholestan-3β,5α-diol recovery for quantification by GC/MS.
Soules R; Noguer E; Iuliano L; Zerbinati C; Leignadier J; Rives A; de Medina P; Silvente-Poirot S; Poirot M
Chem Phys Lipids; 2017 Oct; 207(Pt B):92-98. PubMed ID: 28554594
[TBL] [Abstract][Full Text] [Related]
6. Chemical synthesis and biochemical properties of cholestane-5α,6β-diol-3-sulfonate: A non-hydrolysable analogue of cholestane-5α,6β-diol-3β-sulfate.
de Médina P; Ayadi S; Soulès R; Payre B; Rup-Jacques S; Silvente-Poirot S; Samadi M; Poirot M
J Steroid Biochem Mol Biol; 2023 Nov; 234():106396. PubMed ID: 37683773
[TBL] [Abstract][Full Text] [Related]
7. The tumor-suppressor cholesterol metabolite, dendrogenin A, is a new class of LXR modulator activating lethal autophagy in cancers.
Poirot M; Silvente-Poirot S
Biochem Pharmacol; 2018 Jul; 153():75-81. PubMed ID: 29409832
[TBL] [Abstract][Full Text] [Related]
8. From tamoxifen to dendrogenin A: The discovery of a mammalian tumor suppressor and cholesterol metabolite.
Silvente-Poirot S; de Medina P; Record M; Poirot M
Biochimie; 2016 Nov; 130():109-114. PubMed ID: 27262406
[TBL] [Abstract][Full Text] [Related]
9. Surprising unreactivity of cholesterol-5,6-epoxides towards nucleophiles.
Paillasse MR; Saffon N; Gornitzka H; Silvente-Poirot S; Poirot M; de Medina P
J Lipid Res; 2012 Apr; 53(4):718-25. PubMed ID: 22285872
[TBL] [Abstract][Full Text] [Related]
10. Cholesterol epoxide hydrolase and cancer.
Silvente-Poirot S; Poirot M
Curr Opin Pharmacol; 2012 Dec; 12(6):696-703. PubMed ID: 22917620
[TBL] [Abstract][Full Text] [Related]
11. Plasma oxysterol levels in luminal subtype breast cancer patients are associated with clinical data.
Kloudova-Spalenkova A; Ueng YF; Wei S; Kopeckova K; Peter Guengerich F; Soucek P
J Steroid Biochem Mol Biol; 2020 Mar; 197():105566. PubMed ID: 31874216
[TBL] [Abstract][Full Text] [Related]
12. The Cholesterol-5,6-Epoxide Hydrolase: A Metabolic Checkpoint in Several Diseases.
de Medina P; Ayadi S; Diallo K; Buñay J; Pucheu L; Soulès R; Record M; Brillouet S; Vija L; Courbon F; Silvente-Poirot S; Poirot M
Adv Exp Med Biol; 2024; 1440():149-161. PubMed ID: 38036879
[TBL] [Abstract][Full Text] [Related]
13. Cholesterol-5,6-epoxides: chemistry, biochemistry, metabolic fate and cancer.
Poirot M; Silvente-Poirot S
Biochimie; 2013 Mar; 95(3):622-31. PubMed ID: 22613256
[TBL] [Abstract][Full Text] [Related]
14. 5,6-Epoxy-cholesterols contribute to the anticancer pharmacology of tamoxifen in breast cancer cells.
Segala G; de Medina P; Iuliano L; Zerbinati C; Paillasse MR; Noguer E; Dalenc F; Payré B; Jordan VC; Record M; Silvente-Poirot S; Poirot M
Biochem Pharmacol; 2013 Jul; 86(1):175-89. PubMed ID: 23500540
[TBL] [Abstract][Full Text] [Related]
15. Formation of biologically active oxysterols during ozonolysis of cholesterol present in lung surfactant.
Pulfer MK; Murphy RC
J Biol Chem; 2004 Jun; 279(25):26331-8. PubMed ID: 15096493
[TBL] [Abstract][Full Text] [Related]
16. Identification and pharmacological characterization of cholesterol-5,6-epoxide hydrolase as a target for tamoxifen and AEBS ligands.
de Medina P; Paillasse MR; Segala G; Poirot M; Silvente-Poirot S
Proc Natl Acad Sci U S A; 2010 Jul; 107(30):13520-5. PubMed ID: 20615952
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of Non-Enzymatically Derived Oxysterols: Clues from sterol metabolic disorders.
Griffiths WJ; Yutuc E; Abdel-Khalik J; Crick PJ; Hearn T; Dickson A; Bigger BW; Hoi-Yee Wu T; Goenka A; Ghosh A; Jones SA; Covey DF; Ory DS; Wang Y
Free Radic Biol Med; 2019 Nov; 144():124-133. PubMed ID: 31009661
[TBL] [Abstract][Full Text] [Related]
18. The 5,6-epoxycholesterol metabolic pathway in breast cancer: Emergence of new pharmacological targets.
de Medina P; Diallo K; Huc-Claustre E; Attia M; Soulès R; Silvente-Poirot S; Poirot M
Br J Pharmacol; 2021 Aug; 178(16):3248-3260. PubMed ID: 32696532
[TBL] [Abstract][Full Text] [Related]
19. 7-Ketocholesterol and cholestane-triol increase expression of SMO and LXRα signaling pathways in a human breast cancer cell line.
Levy D; de Melo TC; Oliveira BA; Paz JL; de Freitas FA; Reichert CO; Rodrigues A; Bydlowski SP
Biochem Biophys Rep; 2019 Sep; 19():100604. PubMed ID: 31463370
[TBL] [Abstract][Full Text] [Related]
20. Cholesterol oxides as biomarkers of oxidative stress in type 1 and type 2 diabetes mellitus.
Ferderbar S; Pereira EC; Apolinário E; Bertolami MC; Faludi A; Monte O; Calliari LE; Sales JE; Gagliardi AR; Xavier HT; Abdalla DS
Diabetes Metab Res Rev; 2007 Jan; 23(1):35-42. PubMed ID: 16634125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
